Deuterium based drugs

Byscientist

The news story today is about Concert Pharmaceuticals partnering with Celgene to develop Concert’s deuterated compounds. Concert and Auspex are two pharmaceutical companies pursuing the deuterated compound as a unique drugs but the science is a bit of a mystery.

Hydrogen and its isotope Deuterium exists in nature and thus any compound will exist in its native version with some deuterated hydrogen. These drug companies hope that using the deuterated version of the chemical compound will change its binding property and its metabolism for the better. These companies have convinced some Pharma companies that their drugs are worth investing and will be better from biological point of view but also from a patent point of view.

This issue has been going on since a long time as the Nature link below in 2009 points out. Wonder what the reality is…

Similar Posts

  • New Cancer targets

    Byscientist

    Targets for cancer therapy initially were very specific cell division targets. Nowadays, the targets have become very cancer specific, for e.g. targeting the BCR-ABL to target Chronic Myeloid Leukemia. However, a scientist in Australia has come up with a target that is very unlikely – tropomyosin. Tropomyosin is a protein that along with actin is…

  • |

    Phages as antibacterial

    Byscientist

    Bacteriophages are viruses that attack bacteria killing them. They are inanimate and can be considered dead till they infect the bacteria where they multiply. Phages were approved by the FDA in 2006 for their application in food to control Listeria infections. Link to paper: https://www.gastrojournal.org/article/S0016-5085%2806%2902235-9/fulltext This has continued for sometime, since multiple strains can be…

  • |

    Mesoscale explorer

    Byscientist

    Sometimes it is hard to imagine how many molecules are involved in a common biological pathway but there are thousands of molecules that orchestrate their chemical reactions to sustain life. One such area is the synaptic gap where messages are passed between neurons. This is a very active space where vesicle with messengers cross the…

  • |

    Open source protein models

    Byscientist

    A company called Profluent (profluent.bio) has been developing protein models that can be used for designing new proteins (https://www.nature.com/articles/s41587-022-01618-2), modeling of new CRISPR-Cas sequences (https://www.nature.com/articles/s41586-025-09298-z) and developing LLM for protein generation (https://www.biorxiv.org/content/10.1101/2025.11.12.688125v1.article-info). What is amazing is that they have open sourced all their models and Profluent-E1 is available in GitHub to download and use. (https://github.com/Profluent-AI/E1)…

  • |

    Muscarinic drugs and receptors

    Byscientist

    There are many G-protein coupled receptors and one of the major categories for neurological drug development are called muscarinic receptors because they were first known to be activated by a mushroom alkaloid called muscarine. The isolation and characterization of muscarine was first reported by chemists in 1869! Muscarine works by mimicking the neurotransmitter acteylcholine on…

  • | |

    Heart rate variability

    Byscientist

    By definition, heart rate variability is the time between each heart beat. This is called the R-R interval and shows the beat modulation of the sino-atrial node whose time variation is controlled by the autonomic nervous system. This matters because sympathetic (fight or flight) or parasympathetic (rest and digest) activity governs cardiac dynamics. A higher…